• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻窦炎与炎症性肠病共存的危险因素识别

Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease.

作者信息

Rai Victoria, Traboulsi Cindy, Silfen Alexa, Ackerman Max T, Erondu Amarachi I, Karpin Jordan E, Gulotta George, Rubin David T

机构信息

University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.

出版信息

Crohns Colitis 360. 2021 Jul;3(3). doi: 10.1093/crocol/otab054. Epub 2021 Aug 2.

DOI:10.1093/crocol/otab054
PMID:35531367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075692/
Abstract

BACKGROUND

This study aimed to analyze the association of coexisting sinusitis and IBD, establish significant factors involved in their development, and enable further biological correlation between these two diseases.

METHODS

he BD and inusitis tudy at Chicago Medicin (TISSUe) is a retrospective, single-center study. We reviewed patients to confirm IBD and chronic sinusitis diagnoses. Case-control propensity score matching was performed using matched controls with IBD only or sinusitis only. Statistical methods included Chi-squared test and Wilcoxon rank sum test. Logistic regression analysis was performed, and factors were considered significant if p<0.05.

RESULTS

Stratifying 214 patients with coexisting IBD and sinusitis, 176 patients had IBD first and 38 patients had sinusitis first. Multivariable analysis of factors associated with subsequent disease with matched controls determined that duration of disease, UC, steroid exposure ever, and younger age of IBD diagnosis were associated with subsequent sinusitis in patients with IBD; steroid exposure ever and duration of sinusitis were significantly associated with subsequent IBD in patients with sinusitis.

CONCLUSIONS

This study suggests that IBD maintenance therapies are not associated with increased risk of sinusitis, as proposed by adverse events in clinical trial data; rather, UC diagnosis and duration of disease may be more influential in sinusitis development. While further studies are necessary, this study also demonstrates that sinusitis precedes IBD in some patients, probing its biological association with IBD and possible classification as an extraintestinal manifestation.

摘要

背景

本研究旨在分析并存鼻窦炎与炎症性肠病(IBD)之间的关联,确定其发病过程中的重要因素,并进一步探究这两种疾病之间的生物学相关性。

方法

芝加哥医学院的炎症性肠病与鼻窦炎研究(TISSUe)是一项回顾性单中心研究。我们对患者进行了回顾,以确认炎症性肠病和慢性鼻窦炎的诊断。采用仅患有炎症性肠病或仅患有鼻窦炎的匹配对照进行病例对照倾向评分匹配。统计方法包括卡方检验和威尔科克森秩和检验。进行了逻辑回归分析,若p<0.05,则认为因素具有显著性。

结果

对214例并存炎症性肠病和鼻窦炎的患者进行分层,176例患者先患炎症性肠病,38例患者先患鼻窦炎。对与匹配对照的后续疾病相关因素进行多变量分析,结果显示,疾病持续时间、溃疡性结肠炎(UC)、曾使用类固醇以及炎症性肠病诊断时年龄较小与炎症性肠病患者后续发生鼻窦炎相关;曾使用类固醇和鼻窦炎持续时间与鼻窦炎患者后续发生炎症性肠病显著相关。

结论

本研究表明,如临床试验数据中的不良事件所提示的,炎症性肠病维持治疗与鼻窦炎风险增加无关;相反,溃疡性结肠炎诊断和疾病持续时间可能对鼻窦炎的发生更具影响。虽然还需要进一步研究,但本研究也表明,在一些患者中鼻窦炎先于炎症性肠病出现,这进一步探究了其与炎症性肠病的生物学关联以及作为肠外表现进行分类的可能性。

相似文献

1
Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease.鼻窦炎与炎症性肠病共存的危险因素识别
Crohns Colitis 360. 2021 Jul;3(3). doi: 10.1093/crocol/otab054. Epub 2021 Aug 2.
2
Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease.炎症性肠病患者的住院费用、住院时长及髋膝关节置换术患病率
World J Gastroenterol. 2017 Jul 14;23(26):4752-4758. doi: 10.3748/wjg.v23.i26.4752.
3
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
4
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.炎症性肠病的癌症风险:一项为期 6 年的前瞻性多中心巢式病例对照 IG-IBD 研究。
Inflamm Bowel Dis. 2020 Feb 11;26(3):450-459. doi: 10.1093/ibd/izz155.
5
in Inflammatory Bowel Disease: A Retrospective Study.《炎症性肠病:一项回顾性研究》
Gastroenterol Res Pract. 2017;2017:4803262. doi: 10.1155/2017/4803262. Epub 2017 Oct 4.
6
Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.中东地区炎症性肠病的肠外表现。
J Epidemiol Glob Health. 2020 Dec;10(4):298-303. doi: 10.2991/jegh.k.200330.001. Epub 2020 Apr 12.
7
A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.2010年在克罗地亚东北部武科瓦尔-斯拉沃尼亚县进行的一项关于炎症性肠病传统环境危险因素的回顾性病例对照研究。
Wien Klin Wochenschr. 2015 May;127(9-10):345-54. doi: 10.1007/s00508-015-0741-7. Epub 2015 Mar 28.
8
Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?原发性硬化性胆管炎是否会影响炎症性肠病患者的生活质量?
Inflamm Bowel Dis. 2010 Mar;16(3):494-500. doi: 10.1002/ibd.21051.
9
Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.共存乳糜泻对炎症性肠病表型和自然史的影响。
Am J Gastroenterol. 2013 Jul;108(7):1123-9. doi: 10.1038/ajg.2013.20. Epub 2013 Feb 19.
10
The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.与炎症性肠病相关的皮肤病患者中炎症性肠病延迟诊断的风险
Inflamm Bowel Dis. 2021 Oct 20;27(11):1731-1739. doi: 10.1093/ibd/izaa344.

引用本文的文献

1
The causality between chronic rhinosinusitis and inflammatory bowel disease: A bidirectional 2-sample Mendelian randomization analysis.慢性鼻窦炎与炎症性肠病之间的因果关系:一项双向双样本孟德尔随机化分析。
Medicine (Baltimore). 2025 Sep 5;104(36):e44402. doi: 10.1097/MD.0000000000044402.
2
Co-prevalence of chronic rhinosinusitis and inflammatory bowel disease: A large aggregated electronic health record study.慢性鼻-鼻窦炎与炎症性肠病的共患病率:一项大型汇总电子健康记录研究
Int Forum Allergy Rhinol. 2024 Dec;14(12):1934-1937. doi: 10.1002/alr.23425. Epub 2024 Aug 5.
3
Could Chronic Rhinosinusitis Increase the Risk of Ulcerative Colitis? A Nationwide Cohort Study.

本文引用的文献

1
Adult chronic rhinosinusitis.成人慢性鼻-鼻窦炎。
Nat Rev Dis Primers. 2020 Oct 29;6(1):86. doi: 10.1038/s41572-020-00218-1.
2
Adults with inflammatory bowel disease are at a greater risk of developing chronic rhinosinusitis: A nationwide population-based study.炎症性肠病患者发生慢性鼻-鼻窦炎的风险更高:一项全国性基于人群的研究。
Clin Otolaryngol. 2021 Jan;46(1):196-205. doi: 10.1111/coa.13647. Epub 2020 Oct 21.
3
Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system.
慢性鼻窦炎会增加溃疡性结肠炎的风险吗?一项全国性队列研究。
Diagnostics (Basel). 2022 Sep 28;12(10):2344. doi: 10.3390/diagnostics12102344.
使用美国食品和药物管理局不良事件报告系统评估 vedolizumab 的真实世界安全性概况。
PLoS One. 2019 Dec 4;14(12):e0225572. doi: 10.1371/journal.pone.0225572. eCollection 2019.
4
Inflammatory bowel disease: Looking beyond the tract.炎症性肠病:超越肠道的视野。
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419866567. doi: 10.1177/2058738419866567.
5
Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010.1970年至2010年期间,基于人群的起始队列中按种族和族裔划分的炎症性肠病发病率。
Therap Adv Gastroenterol. 2019 Feb 6;12:1756284819827692. doi: 10.1177/1756284819827692. eCollection 2019.
6
Events Within the First Year of Life, but Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases.生命第一年的事件,而非新生儿期,影响炎症性肠病的后续发展风险。
Gastroenterology. 2019 Jun;156(8):2190-2197.e10. doi: 10.1053/j.gastro.2019.02.004. Epub 2019 Feb 14.
7
Real-World Experience with Tofacitinib in IBD at a Tertiary Center.真实世界中在三级中心使用托法替布治疗炎症性肠病的经验。
Dig Dis Sci. 2019 Jul;64(7):1945-1951. doi: 10.1007/s10620-019-05492-y. Epub 2019 Feb 7.
8
Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.哮喘与炎症性肠病的共病:系统评价和荟萃分析。
Clin Transl Gastroenterol. 2018 Sep 24;9(9):188. doi: 10.1038/s41424-018-0054-z.
9
Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.基于性别的炎症性肠病发病率差异:西方国家基于人群的研究的汇总分析。
Gastroenterology. 2018 Oct;155(4):1079-1089.e3. doi: 10.1053/j.gastro.2018.06.043. Epub 2018 Jun 27.
10
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.维得利珠单抗诱导和维持炎症性肠病的疗效和安全性:12 个月的随访结果
Inflamm Bowel Dis. 2018 Mar 19;24(4):849-860. doi: 10.1093/ibd/izx067.